Charles River Laboratories International (CRL) Cash from Financing Activities (2009 - 2025)

Charles River Laboratories International's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$51.9 million for Q4 2025.

• In Q4 2025, Cash from Financing Activities rose 31.65% year-over-year to -$51.9 million; the TTM figure through Dec 2025 stood at -$536.7 million (up 2.58% YoY), while the FY2025 annual figure was -$536.7 million, up 2.58% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at -$51.9 million, up from -$152.6 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $518.0 million in Q2 2021, with the low at -$285.9 million in Q2 2024.
• The 5-year median for Cash from Financing Activities is -$61.7 million (2023), against an average of -$27.1 million.
• The sharpest annual moves came in 2021 and 2025: Cash from Financing Activities surged 597.57% in 2021, then slumped 674.1% in 2025.
• Charles River Laboratories International's Cash from Financing Activities stood at -$219.0 million in 2021, then fell by 13.69% to -$249.0 million in 2022, then soared by 149.63% to $123.6 million in 2023, then slumped by 161.41% to -$75.9 million in 2024, then surged by 31.65% to -$51.9 million in 2025.
• Business Quant data shows CRL's Cash from Financing Activities at -$51.9 million in Q4 2025, -$152.6 million in Q3 2025, and -$226.9 million in Q2 2025.